HSIC vs. COO, IDXX, MASI, MMSI, AMN, AVNS, BRBR, NVST, WST, and PDCO
Should you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Masimo (MASI), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Avanos Medical (AVNS), BellRing Brands (BRBR), Envista (NVST), West Pharmaceutical Services (WST), and Patterson Companies (PDCO).
Henry Schein vs. Its Competitors
Cooper Companies (NASDAQ:COO) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.
Cooper Companies has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.
Cooper Companies currently has a consensus price target of $99.70, indicating a potential upside of 36.56%. Henry Schein has a consensus price target of $79.30, indicating a potential upside of 6.21%. Given Cooper Companies' stronger consensus rating and higher probable upside, research analysts clearly believe Cooper Companies is more favorable than Henry Schein.
In the previous week, Cooper Companies had 16 more articles in the media than Henry Schein. MarketBeat recorded 27 mentions for Cooper Companies and 11 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.24 beat Cooper Companies' score of 0.37 indicating that Henry Schein is being referred to more favorably in the news media.
Cooper Companies has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 2.0% of Cooper Companies shares are held by company insiders. Comparatively, 1.1% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Cooper Companies has a net margin of 10.39% compared to Henry Schein's net margin of 3.21%. Henry Schein's return on equity of 14.87% beat Cooper Companies' return on equity.
Summary
Cooper Companies beats Henry Schein on 11 of the 17 factors compared between the two stocks.
Get Henry Schein News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Henry Schein Competitors List
Related Companies and Tools
This page (NASDAQ:HSIC) was last updated on 7/6/2025 by MarketBeat.com Staff